An improved orthotopic rat bladder tumor model using Dil-loaded fluorescent AY-27 cells
- PMID: 20404568
- DOI: 10.4161/cbt.9.12.11638
An improved orthotopic rat bladder tumor model using Dil-loaded fluorescent AY-27 cells
Abstract
Here we evaluate an improved orthotopic rat bladder tumor model, to be used for the evaluation of the therapeutic potential of novel cancer therapeutics. Before instilling AY-27 tumor cells into chemically denudated rat bladders, AY-27 cells were labeled with the fluorescent carbocyanine dye 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine (DiI). We found that the presence of Dil did not alter the in vitro AY-27 cell proliferation and that the Dil label was strongly associated with the cells. We further provide evidence that the use of fluorescently labeled AY-27 tumor cells allows the visualization and hence the validation of the orthotopic tumor inoculation process. Using this technique it was possible to track down the tumor cells after inoculation into the bladder, which makes it straightforward to distinguish tumor cells from remaining or regenerated normal urothelium over a period of 5 d. The results also demonstrated that malignant AY-27 tissue exists as an intact non-muscle invasive bladder tumor only for 1-3 d after cell implantation. Accordingly the AY-27 bladder tumor model was used to evaluate the antitumoral effect of a single intravesical MM-C instillation. All rats instilled with 1 mM MM-C survived the final endpoint of 30 d after intravesical MM-C. Moreover, 10 and 30 d after treatment the urothelium of the MM-C-treated animals was completely restored. Remarkably, after MM-C treatment distinct patchy fluorescent dots were found into the submucosa and the regenerated urothelium, suggesting that dye retention is secondary to the digestion of Dil-loaded AY-27 cells and cellular debris by macrophages and related immune cells.
Similar articles
-
Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy.BJU Int. 2015 Sep;116(3):468-77. doi: 10.1111/bju.13113. Epub 2015 Apr 30. BJU Int. 2015. PMID: 25754262
-
Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.J Urol. 1992 May;147(5):1404-10. doi: 10.1016/s0022-5347(17)37583-3. J Urol. 1992. PMID: 1569696
-
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.World J Urol. 2018 Nov;36(11):1719-1725. doi: 10.1007/s00345-018-2334-3. Epub 2018 May 16. World J Urol. 2018. PMID: 29767328 Free PMC article.
-
Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.Can J Urol. 2006 Dec;13(6):3317-20. Can J Urol. 2006. PMID: 17187694 Review.
-
Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.Expert Opin Drug Deliv. 2008 Jan;5(1):137-45. doi: 10.1517/17425247.5.1.137. Expert Opin Drug Deliv. 2008. PMID: 18095933 Review.
Cited by
-
Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model.Ther Adv Urol. 2018 Mar 19;10(7):213-221. doi: 10.1177/1756287218762064. eCollection 2018 Jul. Ther Adv Urol. 2018. PMID: 30034540 Free PMC article.
-
Comparison of tumor growth assessment using GFP fluorescence and DiI labeling in a zebrafish xenograft model.Cancer Biol Ther. 2023 Dec 31;24(1):2234140. doi: 10.1080/15384047.2023.2234140. Cancer Biol Ther. 2023. PMID: 37455418 Free PMC article.
-
Advances in Intravital Non-Linear Optical Imaging of the Central Nervous System in Rodents.Brain Plast. 2016 Dec 21;2(1):31-48. doi: 10.3233/BPL-160028. Brain Plast. 2016. PMID: 29765847 Free PMC article. Review.
-
Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer.Adv Sci (Weinh). 2023 Mar;10(7):e2204643. doi: 10.1002/advs.202204643. Epub 2023 Jan 13. Adv Sci (Weinh). 2023. PMID: 36638276 Free PMC article.
-
Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue.Cancer Sci. 2013 May;104(5):631-8. doi: 10.1111/cas.12123. Epub 2013 Mar 24. Cancer Sci. 2013. PMID: 23384396 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials